Lazard Asset Management
SILO icon

Lazard Asset Management’s Silo Pharma SILO Stock Holding History

Lazard Asset Management’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38
Closed – – 2514
2025
Q1 		$0 Sell
38
-26
-41% -$582 ﹤0.01% 2555
2024
Q4 		$0 Sell
64
-4
-6% -$62 ﹤0.01% 2517
2024
Q3 		$1K Buy
+68
New +$1.45K ﹤0.01% 2205

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UFM
Ursa Fund Management Danville, California $108M AUM 30.27% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Lazard Asset Management's SILO Position: Q2 2025 in Review

Lazard Asset Management sold out of Silo Pharma (SILO) in Q2 2025, closing a stake of 38 shares.

Lazard Asset Management first reported a position in SILO in Q3 2024 and held it in 3 quarters. The position peaked at $1K in Q3 2024. 13 funds tracked by Wall St. Rank hold SILO as of Q2 2025.

  • Lazard Asset Management reported no remaining Silo Pharma position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 38 Silo Pharma shares in Q2 2025.
  • Lazard Asset Management first reported a position in Silo Pharma in Q3 2024 and held it in 3 quarters.
  • Lazard Asset Management's Silo Pharma position peaked at $1K in Q3 2024.
  • 13 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.